| Year |
Citation |
Score |
| 2024 |
Wang J, Fan T, Zhang S, Wu C, Huang R. Letter: Association of serum growth differentiation factor 15 and liver-related outcomes in patients with MASLD. Alimentary Pharmacology & Therapeutics. PMID 39075785 DOI: 10.1111/apt.18150 |
0.332 |
|
| 2024 |
Zhang S, Zhang Q, Wang J, Pan Y, Zhang Z, Geng Y, Jia B, Tian B, Xiong Y, Yan X, Li J, Wang H, Huang R, Wu C. Red Blood Cell Distribution Width Predicts Mortality in Hospitalized Patients with Severe Fever with Thrombocytopenia Syndrome. Journal of Inflammation Research. 17: 4895-4904. PMID 39070134 DOI: 10.2147/JIR.S468388 |
0.314 |
|
| 2024 |
Rui F, Xu L, Yeo YH, Xu Y, Ni W, Tan Y, Zheng Q, Tian X, Zeng QL, He Z, Qiu Y, Zhu C, Ding W, Wang J, Huang R, et al. Machine learning-based models for advanced fibrosis and cirrhosis diagnosis in chronic hepatitis B patients with hepatic steatosis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 38906440 DOI: 10.1016/j.cgh.2024.06.014 |
0.363 |
|
| 2024 |
Wang J, Zhang S, Jiang C, Wu C, Huang R. The HEPSANET score to assess treatment eligibility of chronic hepatitis B in Africa. The Lancet. Gastroenterology & Hepatology. 9: 589. PMID 38870962 DOI: 10.1016/S2468-1253(24)00114-6 |
0.34 |
|
| 2024 |
Wang J, Zhu L, Zhang Z, Zhang S, Pan Y, Li Y, Cao F, Jiang C, Fan T, Xiong Y, Liu J, Chen Y, Yin S, Tong X, Zhu C, et al. Lower HBV DNA level is associated with more severe liver fibrosis in HBeAg-positive chronic hepatitis B with normal alanine transaminase. Virology Journal. 21: 127. PMID 38835029 DOI: 10.1186/s12985-024-02368-0 |
0.359 |
|
| 2024 |
Wang J, Zhang Z, Zhu C, Wu C, Huang R. Clinical utility of the treatment eligibility score HEPSANET for chronic hepatitis B in Asia. The Lancet Regional Health. Western Pacific. 47: 101097. PMID 38812843 DOI: 10.1016/j.lanwpc.2024.101097 |
0.348 |
|
| 2024 |
Wang J, Pan Y, Xiong Y, Wu C, Huang R. Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients. Alimentary Pharmacology & Therapeutics. PMID 38643497 DOI: 10.1111/apt.17971 |
0.352 |
|
| 2024 |
Zhang S, Wang J, Zhang Q, Pan Y, Zhang Z, Geng Y, Jia B, Li Y, Xiong Y, Yan X, Li J, Wang H, Wu C, Huang R. Association of liver function and prognosis in patients with severe fever with thrombocytopenia syndrome. Plos Neglected Tropical Diseases. 18: e0012068. PMID 38626222 DOI: 10.1371/journal.pntd.0012068 |
0.35 |
|
| 2024 |
Ou M, Zhang W, Zhang W, Guo J, Huang R, Wang J, Liu J, Xia J, Wu C, Zhu Y, Chen Y. Soluble Programmed Cell Death 1 Protein Is a Promising Biomarker to Predict Severe Liver Inflammation in Chronic Hepatitis B Patients. Acs Omega. 9: 16716-16724. PMID 38617617 DOI: 10.1021/acsomega.4c00780 |
0.373 |
|
| 2024 |
Wang J, Zhang S, Zhang Z, Wu C, Huang R. Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D. Alimentary Pharmacology & Therapeutics. 59: 1158-1159. PMID 38591798 DOI: 10.1111/apt.17923 |
0.35 |
|
| 2024 |
Wang J, Zhu L, Zhang S, Zhang Z, Fan T, Cao F, Xiong Y, Pan Y, Li Y, Jiang C, Yin S, Tong X, Xiong Y, Xia J, Yan X, et al. Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA. Emerging Microbes & Infections. 2339944. PMID 38584592 DOI: 10.1080/22221751.2024.2339944 |
0.373 |
|
| 2024 |
Wang J, Fan T, Zhang S, Wu C, Huang R. Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics. 59: 1012-1013. PMID 38523126 DOI: 10.1111/apt.17922 |
0.345 |
|
| 2024 |
Rui F, Yeo YH, Xu L, Zheng Q, Xu X, Ni W, Tan Y, Zeng QL, He Z, Tian X, Xue Q, Qiu Y, Zhu C, Ding W, Wang J, et al. Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort study. Eclinicalmedicine. 68: 102419. PMID 38292041 DOI: 10.1016/j.eclinm.2023.102419 |
0.366 |
|
| 2024 |
Huang R, Liu J, Wang J, Qiu Y, Zhu L, Li Y, Liu Y, Zhan J, Xue R, Jiang S, Geng Y, Wan Y, Li M, Mao M, Gao D, et al. Histological features of chronic hepatitis B patients with normal alanine aminotransferase according to different criteria. Hepatology Communications. 8. PMID 38206209 DOI: 10.1097/HC9.0000000000000357 |
0.429 |
|
| 2023 |
Chen Y, Liu J, Wang J, Wu W, Wang H, Liu Y, Zhang Z, Zhang S, Pan Y, Li Y, Ding W, Zhu L, Zhu C, Li J, Qiu Y, et al. Liver inflammation activity in patients with autoimmune hepatitis with normal alanine aminotransferase and immunoglobulin G levels. Journal of Translational Autoimmunity. 8: 100220. PMID 38188039 DOI: 10.1016/j.jtauto.2023.100220 |
0.402 |
|
| 2023 |
Zhan J, Wang J, Zhang Z, Xue R, Jiang S, Liu J, Liu Y, Zhu L, Xia J, Yan X, Ding W, Zhu C, Qiu Y, Li J, Huang R, et al. Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase. Virulence. 14: 2268497. PMID 37938933 DOI: 10.1080/21505594.2023.2268497 |
0.439 |
|
| 2023 |
Yang S, Zhang L, Jin Q, Wang J, Ma D, Gao J, Huang R. Meld-sarcopenia score and skeletal muscle density predicts short-term readmission of patients with hepatic encephalopathy. European Journal of Radiology. 169: 111178. PMID 37922620 DOI: 10.1016/j.ejrad.2023.111178 |
0.347 |
|
| 2023 |
Zhang Z, Wang J, Chen Y, Li Y, Zhu L, Wang H, Liu Y, Liu J, Yin S, Tong X, Yan X, Chen Y, Zhu C, Li J, Qiu Y, et al. A novel web-based online nomogram to predict advanced liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome. Journal of Translational Autoimmunity. 7: 100215. PMID 37877134 DOI: 10.1016/j.jtauto.2023.100215 |
0.41 |
|
| 2023 |
Xu Q, Ding H, Bai T, Huang R, Wang J, Zhang J, Luan H, Wang J, Yang Y, Chen Y. Serum HBV RNA levels among untreated adults with chronic hepatitis B in distinct immune phases and liver histopathology statuses. Journal of Molecular Histology. PMID 37843699 DOI: 10.1007/s10735-023-10162-5 |
0.399 |
|
| 2023 |
Huang R, Zhang Z, Wang J, Zhang S, Wu C. Letter: Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics. 58: 965-966. PMID 37831536 DOI: 10.1111/apt.17712 |
0.398 |
|
| 2023 |
Yao R, Lu S, Xue R, Wang J, Qiu Y, Chen Y, Liu J, Zhu L, Zhan J, Jiang S, Yin S, Tong X, Ding W, Li J, Zhu C, et al. NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study. Annals of Hepatology. 101155. PMID 37742745 DOI: 10.1016/j.aohep.2023.101155 |
0.426 |
|
| 2023 |
Gu Y, Zhang Y, Zhang Z, Wang J, Zhang Q, Zhang S, Liu Y, Liu J, Xia J, Yan X, Li J, Liu X, Huang R, Wu C. A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues. Annals of Hepatology. 101151. PMID 37704066 DOI: 10.1016/j.aohep.2023.101151 |
0.417 |
|
| 2023 |
Yin S, Wan Y, Issa R, Zhu Y, Xu X, Liu J, Mao M, Li M, Tong X, Tian C, Wang J, Huang R, Zhang Q, Wu C, Chen Y, et al. The Presence of Baseline HBsAb-Specific B Cells Can Predict HBsAg or HBeAg seroconversion of Chronic Hepatitis B on treatment. Emerging Microbes & Infections. 2259003. PMID 37702202 DOI: 10.1080/22221751.2023.2259003 |
0.409 |
|
| 2023 |
Jiang S, Wang J, Zhang Z, Zhan J, Xue R, Qiu Y, Zhu L, Zhang S, Pan Y, Yan X, Chen Y, Li J, Liu X, Zhu C, Huang R, et al. Development and Validation of a Nomogram to Predict Significant Liver Inflammation in Patients with Chronic Hepatitis B. Infection and Drug Resistance. 16: 5065-5075. PMID 37576516 DOI: 10.2147/IDR.S417007 |
0.438 |
|
| 2023 |
Zhang L, Zhang W, Wang J, Jin Q, Ma D, Huang R. Neutrophil-to-lymphocyte ratio predicts 30-, 90-, and 180-day readmissions of patients with hepatic encephalopathy. Frontiers in Medicine. 10: 1185182. PMID 37457569 DOI: 10.3389/fmed.2023.1185182 |
0.405 |
|
| 2023 |
Zhang Z, Wang J, Wang H, Li Y, Zhu L, Chen Y, Liu J, Liu Y, Chen Y, Yin S, Tong X, Yan X, Yang Y, Zhu C, Li J, et al. Develop and validate a novel online AIHI-nomogram to predict severe liver inflammation in patients with autoimmune hepatitis. Annals of Hepatology. 101134. PMID 37442347 DOI: 10.1016/j.aohep.2023.101134 |
0.417 |
|
| 2023 |
Yin S, Wang J, Chen L, Mao M, Rahma I, Geng Y, Huang R, Tong X, Liu Y, Wu C, Chen Y, Li J. Circulating Th2-biased T follicular helper cells impede antiviral humoral responses during chronic hepatitis B infection through upregulating CTLA4. Antiviral Research. 105665. PMID 37421985 DOI: 10.1016/j.antiviral.2023.105665 |
0.374 |
|
| 2023 |
Zhang Y, Gu Y, Yin S, Wang J, Zhang Z, Liu Y, Chen Y, Zhan J, Xue R, Yan X, Zhang S, Ding W, Chen Y, Li J, Huang R, et al. Baseline albumin-bilirubin score: a predictor for HBeAg clearance in patients with chronic hepatitis B after nucleos(t)ide analogue treatment. European Journal of Gastroenterology & Hepatology. PMID 37395182 DOI: 10.1097/MEG.0000000000002598 |
0.415 |
|
| 2023 |
Zhang Z, Wang J, Wang H, Qiu Y, Zhu L, Liu J, Chen Y, Li Y, Liu Y, Chen Y, Yin S, Tong X, Yan X, Xiong Y, Yang Y, et al. An easy-to-use AIHF-nomogram to predict advanced liver fibrosis in patients with autoimmune hepatitis. Frontiers in Immunology. 14: 1130362. PMID 37266419 DOI: 10.3389/fimmu.2023.1130362 |
0.419 |
|
| 2023 |
Pan YR, Liu SQ, He YS, Xue Y, Wang J, Huang R, Wu C, Lu JC, Liu LG. Estimated glomerular filtration rate partially recovered in patients without Hypertriglyceridemia during Tenofovir disoproxil fumarate treatment. Annals of Medicine. 55: 760-765. PMID 36856541 DOI: 10.1080/07853890.2023.2177725 |
0.318 |
|
| 2023 |
Huang R, Wang J, Yan X, Zhu C, Wu C. Editorial: considerations for expanding treatment in grey zone chronic hepatitis B patients-authors' reply. Alimentary Pharmacology & Therapeutics. 57: 579-580. PMID 36786454 DOI: 10.1111/apt.17369 |
0.408 |
|
| 2023 |
Huang R, Wang J, Yan X, Zhu C, Wu C. Letter: improved alanine aminotransferase level in non-cirrhotic and low-viral load chronic hepatitis B patients treated with nucleotide/nucleoside analogues -authors' reply. Alimentary Pharmacology & Therapeutics. 57: 589-590. PMID 36786453 DOI: 10.1111/apt.17367 |
0.403 |
|
| 2023 |
Wang J, Huang R, Liu J, Lai R, Liu Y, Zhu C, Qiu Y, Zebao H, Yin S, Chen Y, Yan X, Ding W, Zheng Q, Li J, Wu C. A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of Viral Hepatitis. PMID 36696366 DOI: 10.1111/jvh.13808 |
0.415 |
|
| 2023 |
Ding S, Ma T, Huang R, Wang H, Liu J, Wang J, Fan X, Li J, Wu C, Zhou N, Fan H. Repeated COVID-19 Relapse of an Imported Patient Infected with SARS-CoV-2 Delta Variant of Concern. Clinical Laboratory. 69. PMID 36649514 DOI: 10.7754/Clin.Lab.2022.220201 |
0.353 |
|
| 2022 |
Liu SQ, Zhang XJ, Xue Y, Huang R, Wang J, Wu C, He YS, Pan YR, Liu LG. Dynamic changes of estimated glomerular filtration rate are conversely related to triglyceride in non-overweight patients. World Journal of Clinical Cases. 10: 11371-11380. PMID 36387799 DOI: 10.12998/wjcc.v10.i31.11371 |
0.312 |
|
| 2022 |
Wang J, Yan X, Zhu L, Liu J, Qiu Y, Li Y, Liu Y, Xue R, Zhan J, Jiang S, Geng Y, Wan Y, Li M, Mao M, Gao D, et al. Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone. Alimentary Pharmacology & Therapeutics. PMID 36324235 DOI: 10.1111/apt.17272 |
0.418 |
|
| 2022 |
Wang J, Liu J, Liu Y, Xue R, Zhan J, Jiang S, Wang L, Yan X, Xiong Y, Xia J, Yin S, Tong X, Chen Y, Li J, Huang R, et al. Clinical features of chronic hepatitis B patients with lean non-alcoholic fatty liver disease. Hepatology Research : the Official Journal of the Japan Society of Hepatology. PMID 36317959 DOI: 10.1111/hepr.13854 |
0.408 |
|
| 2022 |
Tong X, Song Y, Yin S, Wang J, Huang R, Wu C, Shi J, Li J. Clinical impact and mechanisms in hepatitis B virus infection concurrent with non-alcoholic fatty liver disease. Chinese Medical Journal. PMID 35940901 DOI: 10.1097/CM9.0000000000002310 |
0.426 |
|
| 2022 |
Ma T, Ding S, Huang R, Wang H, Wang J, Liu J, Wang J, Li J, Wu C, Fan H, Zhou N. The latent period of coronavirus disease 2019 with SARS-CoV-2 B.1.617.2 Delta variant of concern in the postvaccination era. Immunity, Inflammation and Disease. 10: e664. PMID 35759239 DOI: 10.1002/iid3.664 |
0.323 |
|
| 2022 |
Li XH, Huang R, Yang M, Wang J, Gao YH, Jin Q, Ma DL, Wei L, Rao HY. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral. World Journal of Gastroenterology. 28: 2214-2226. PMID 35721884 DOI: 10.3748/wjg.v28.i20.2214 |
0.399 |
|
| 2022 |
Wang J, Zhu L, Liu L, Yan X, Xue L, Huang S, Zhang B, Xu T, Ji F, Li C, Ming F, Zhao Y, Cheng J, Chen K, Zhao XA, et al. Clinical features and prognosis of COVID-19 patients with metabolic syndrome: A multicenter, retrospective study. Medicina Clinica (English Ed.). 158: 458-465. PMID 35702719 DOI: 10.1016/j.medcle.2021.05.022 |
0.317 |
|
| 2022 |
Wang J, Ding W, Liu J, Liu Y, Yan X, Xia J, Wu W, Jia B, Chen Y, Gao D, Hong S, Wang X, Wang L, Tong X, Yin S, et al. Association of Coexistent Hepatitis B Surface Antigen and Antibody With Severe Liver Fibrosis and Cirrhosis in Treatment-Naive Patients With Chronic Hepatitis B. Jama Network Open. 5: e2216485. PMID 35696167 DOI: 10.1001/jamanetworkopen.2022.16485 |
0.425 |
|
| 2022 |
Zhang Q, Zhu L, Wang J, Liu L, Zhao Y, Xue L, Li Y, Yan X, Cheng J, Xu T, Liu J, Zhan J, Xue R, Zhao XA, Huang R, et al. Clinical Features and Outcomes of Patients with COVID-19 After Discharge: A Retrospective, Multi-center Study. Discovery Medicine. 32: 39-47. PMID 35219355 |
0.336 |
|
| 2022 |
Yeo YH, Gao X, Wang J, Li Q, Su X, Geng Y, Huang R, Wu C, Ji F, Sundaram V, Noureddin M, Buti M, Ayoub WS. The impact of COVID-19 on the cascade of care of HCV in the US and China. Annals of Hepatology. 100685. PMID 35192964 DOI: 10.1016/j.aohep.2022.100685 |
0.311 |
|
| 2022 |
Wu W, Zhang X, Chen Y, Wang B, Wu J, Xiong Y, Jia B, Wang J, Xia J, Pu Y, Zhou W, Chen Z, Zhang Z, Yan X, Huang R, et al. Risk Factors of Fatal Outcome of Hospitalized Patients with COVID-19. Discovery Medicine. 31: 121-127. PMID 35188886 |
0.317 |
|
| 2021 |
Zhao XA, Wang J, Wei J, Liu J, Chen G, Wang L, Wang G, Xia J, Wu W, Yin S, Tong X, Yan X, Ding W, Xiang X, Huang R, et al. Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase. Journal of Clinical and Translational Hepatology. 10: 247-253. PMID 35528978 DOI: 10.14218/JCTH.2021.00151 |
0.436 |
|
| 2021 |
Liu J, Wang J, Yan X, Xue R, Zhan J, Jiang S, Geng Y, Liu Y, Mao M, Xia J, Yin S, Tong X, Chen Y, Ding W, Huang R, et al. Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis. Hepatology Communications. PMID 34783181 DOI: 10.1002/hep4.1859 |
0.418 |
|
| 2021 |
Huang R, Liu J, Wang J, Li J, Wu C. Letter to the Editor: Is hepatitis B virus genotype strongly associated with hepatocellular carcinoma risk in patients with chronic hepatitis B? Hepatology (Baltimore, Md.). PMID 34519071 DOI: 10.1002/hep.32155 |
0.393 |
|
| 2021 |
Yao K, Wang J, Wang L, Xia J, Yan X, Wu W, Liu J, Wang L, Yin S, Tong X, Ding W, Huang R, Wu C. Association of anti-HBc and liver inflammation in HBeAg-negative chronic hepatitis B virus infected patients with normal ALT and detectable HBV DNA. Journal of Medical Virology. PMID 34499353 DOI: 10.1002/jmv.27327 |
0.431 |
|
| 2021 |
Zhao XA, Wang J, Liu J, Chen G, Yan X, Jia B, Yang Y, Liu Y, Gu D, Zhang Z, Xiang X, Huang R, Wu C. Baseline serum hepatitis B core antibody level predicts HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B after antiviral treatment. Antiviral Research. 105146. PMID 34314774 DOI: 10.1016/j.antiviral.2021.105146 |
0.396 |
|
| 2021 |
Huang R, Zhu L, Xue L, Yan X, Wang J, Huang S, Zhang B, Xu T, Ji F, Li C, Ming F, Zhao Y, Li Y, Cheng J, Wang Y, et al. Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study. Virology Journal. 18: 147. PMID 34261488 DOI: 10.1186/s12985-021-01615-y |
0.353 |
|
| 2021 |
Wang J, Zhu L, Liu L, Yan X, Xue L, Huang S, Zhang B, Xu T, Ji F, Li C, Ming F, Zhao Y, Cheng J, Chen K, Zhao XA, et al. Clinical features and prognosis of COVID-19 patients with metabolic syndrome: A multicenter, retrospective study. Medicina Clinica. PMID 34243955 DOI: 10.1016/j.medcli.2021.05.014 |
0.317 |
|
| 2021 |
Yao R, Zhu L, Wang J, Liu J, Xue R, Xue L, Liu L, Li C, Zhao H, Cheng J, Huang S, Li Y, Zhao XA, Zhu C, Li M, et al. Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores. Journal of Clinical Laboratory Analysis. e23880. PMID 34213039 DOI: 10.1002/jcla.23880 |
0.399 |
|
| 2021 |
Zhao XA, Wang J, Chang H, Liu Y, Chen Y, Chen G, Huang R, Wu C. Intrahepatic Expression of C-C Motif ligand 5 in Patients with Chronic Hepatitis B. The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology. 32: 76-81. PMID 33893769 DOI: 10.5152/tjg.2020.19566 |
0.532 |
|
| 2021 |
Huang R, Liu J, Wang J, Wu C. Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis. Alimentary Pharmacology & Therapeutics. 53: 1040-1041. PMID 33831236 DOI: 10.1111/apt.16273 |
0.511 |
|
| 2021 |
Yao K, Liu J, Wang J, Yan X, Xia J, Yang Y, Wu W, Liu Y, Chen Y, Zhang Z, Li J, Huang R, Wu C. Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the gray zone. Journal of Viral Hepatitis. PMID 33797145 DOI: 10.1111/jvh.13511 |
0.521 |
|
| 2021 |
Huang R, Liu J, Wang J, Yan X, Wu C. Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics. 53: 761-762. PMID 33599329 DOI: 10.1111/apt.16264 |
0.406 |
|
| 2021 |
Huang R, Rao HY, Yang M, Gao YH, Wang J, Jin Q, Ma DL, Wei L. Histopathology and the predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy. World Journal of Gastroenterology. 27: 404-415. PMID 33584072 DOI: 10.3748/wjg.v27.i5.404 |
0.388 |
|
| 2021 |
Huang R, Liu J, Wang J, Wu C. Letter: rates and determinants of significant liver inflammation in chronic hepatitis B virus-infected patients with low ALT levels in the absence of significant fibrosis. Alimentary Pharmacology & Therapeutics. 53: 213-214. PMID 33333604 DOI: 10.1111/apt.16164 |
0.426 |
|
| 2020 |
Wang J, Zhu L, Xue L, Liu L, Yan X, Yan X, Huang S, Zhang B, Xu T, Li C, Ji F, Ming F, Zhao Y, Cheng J, Shao H, et al. Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: a retrospective, multi-center study. Journal of Medical Virology. PMID 33174624 DOI: 10.1002/jmv.26663 |
0.39 |
|
| 2020 |
Huang R, Wang J, Zhu C, Wu C. Reply to comment: "Can red blood cell distribution width predict the severity and prognosis of hepatitis B virus-related diseases?" Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 32952070 DOI: 10.1016/j.dld.2020.08.019 |
0.373 |
|
| 2020 |
Huang R, Xia J, Wang J, Chen Y, Wu C. Letter: programmed death-1-a predictor for antiviral treatment in chronic hepatitis B. Authors' reply. Alimentary Pharmacology & Therapeutics. 52: 749-750. PMID 32886394 DOI: 10.1111/apt.15924 |
0.37 |
|
| 2020 |
Wang H, Wang J, Xia J, Yan X, Feng Y, Li L, Chen J, Liu D, Ding W, Yang Y, Huang R, Wu C. Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitis. Medicine. 99: e21408. PMID 32846758 DOI: 10.1097/Md.0000000000021408 |
0.402 |
|
| 2020 |
Huang R, Zhu L, Wang J, Xue L, Liu L, Yan X, Huang S, Li Y, Yan X, Zhang B, Xu T, Li C, Ji F, Ming F, Zhao Y, et al. Clinical features of COVID-19 patients with non-alcoholic fatty liver disease. Hepatology Communications. PMID 32838108 DOI: 10.1002/hep4.1592 |
0.39 |
|
| 2020 |
Zhao X, Zhang L, Bai J, Wu P, Li Y, Liang L, Xie L, Wang J. A copper-based metal-organic framework for ratiometric detection of hydrogen sulfide with high sensitivity and fast response. Spectrochimica Acta. Part a, Molecular and Biomolecular Spectroscopy. 243: 118794. PMID 32799192 DOI: 10.1016/j.saa.2020.118794 |
0.598 |
|
| 2020 |
Wang J, Zhu L, Liu L, Zhao XA, Zhang Z, Xue L, Yan X, Huang S, Li Y, Cheng J, Zhang B, Xu T, Li C, Ji F, Ming F, et al. Overweight and obesity are risks factors of severe illness in patients with COVID-19. Obesity (Silver Spring, Md.). PMID 32735706 DOI: 10.1002/oby.22979 |
0.308 |
|
| 2020 |
Huang J, Su Z, Huang M, Zhang R, Wang J, Feng X, Zhang R, Zhang R, Shan W, Yan XY, Guo QY, Liu T, Liu Y, Cui Y, Li X, et al. Spherical Supramolecular Structures Constructed via Chemically Symmetric Perylene Bisimides: Beyond Columnar Assembly. Angewandte Chemie (International Ed. in English). PMID 32656991 DOI: 10.1002/Anie.201914889 |
0.526 |
|
| 2020 |
Li Y, Li C, Wang J, Zhu C, Zhu L, Ji F, Liu L, Xu T, Zhang B, Xue L, Yan X, Huang R, Wu C, Yan X. A case series of COVID-19 patients with chronic hepatitis B virus infection. Journal of Medical Virology. PMID 32558945 DOI: 10.1002/jmv.26201 |
0.428 |
|
| 2020 |
Chen Y, Tong X, Wang J, Huang W, Yin S, Huang R, Yang H, Chen Y, Huang A, Liu Y, Chen Y, Yuan L, Yan X, Shen H, Wu C. High SARS-CoV-2 Antibody Prevalence among Healthcare Workers Exposed to COVID-19 Patients. The Journal of Infection. PMID 32504745 DOI: 10.1016/j.jinf.2020.05.067 |
0.335 |
|
| 2020 |
Li Y, Yin S, Chen Y, Zhang Q, Huang R, Jia B, Jie W, Yao K, Wang J, Tong X, Liu Y, Wu C. Hepatitis B virus-induced hyperactivation of B cells in chronic hepatitis B patients via TLR4. Journal of Cellular and Molecular Medicine. PMID 32391647 DOI: 10.1111/jcmm.15202 |
0.379 |
|
| 2020 |
Huang R, Zhu L, Xue L, Liu L, Yan X, Wang J, Zhang B, Xu T, Ji F, Zhao Y, Cheng J, Wang Y, Shao H, Hong S, Cao Q, et al. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study. Plos Neglected Tropical Diseases. 14: e0008280. PMID 32384078 DOI: 10.1371/journal.pntd.0008280 |
0.352 |
|
| 2020 |
Xia J, Huang R, Chen Y, Liu Y, Wang J, Yan X, Zhang Z, Wu C. Profiles of serum soluble programmed death-1 and programmed death-ligand 1 levels in chronic hepatitis B virus-infected patients with different disease phases and after anti-viral treatment. Alimentary Pharmacology & Therapeutics. PMID 32363582 DOI: 10.1111/apt.15732 |
0.362 |
|
| 2020 |
Xu T, Huang R, Zhu L, Wang J, Cheng J, Zhang B, Zhao H, Chen K, Shao H, Zhu C, Wu C, Liu L. Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection. Journal of Medical Virology. PMID 32346873 DOI: 10.1002/jmv.25944 |
0.344 |
|
| 2020 |
Zhu L, Wang J, Huang R, Liu L, Zhao H, Wu C, Zhu C. Clinical characteristics of a case series of children with coronavirus disease 2019. Pediatric Pulmonology. PMID 32270592 DOI: 10.1002/ppul.24767 |
0.342 |
|
| 2020 |
Huang R, Wang J, Xia J, Wu C. Reply to the letter by Beyan et al "Plateletcrit may not be an index for predicting of liver fibrosis in patients with chronic hepatitis B". Journal of Viral Hepatitis. PMID 32196845 DOI: 10.1111/jvh.13288 |
0.404 |
|
| 2020 |
Wang J, Xia J, Yan X, Yang Y, Wei J, Xiong Y, Wu W, Liu Y, Chen Y, Jia B, Chen Z, Zhang Z, Ding W, Huang R, Wu C. The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase. Clinics and Research in Hepatology and Gastroenterology. PMID 32147439 DOI: 10.1016/j.clinre.2020.01.011 |
0.431 |
|
| 2020 |
Wang J, Huang R, Yan X, Li M, Chen Y, Xia J, Liu Y, Jia B, Zhu L, Zhang Z, Zhu C, Wu C. Red blood cell distribution width: A promising index for evaluating the severity and long-term prognosis of hepatitis B virus-related diseases. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 32008975 DOI: 10.1016/j.dld.2019.12.144 |
0.39 |
|
| 2020 |
Wang J, Xia J, Yan X, Yang Y, Wei J, Xiong Y, Wu W, Liu Y, Chen Y, Jia B, Chen Z, Zhang Z, Ding W, Huang R, Wu C. Plateletcrit as a potential index for predicting liver fibrosis in chronic hepatitis B. Journal of Viral Hepatitis. PMID 31981279 DOI: 10.1111/jvh.13264 |
0.419 |
|
| 2020 |
Bai J, Wang J, Ravula T, Im SC, Anantharamaiah GM, Waskell L, Ramamoorthy A. Expression, purification, and functional reconstitution of F-labeled cytochrome b5 in peptide nanodiscs for NMR studies. Biochimica Et Biophysica Acta. Biomembranes. 183194. PMID 31953231 DOI: 10.1016/J.Bbamem.2020.183194 |
0.731 |
|
| 2019 |
Wang J, Chen Z, Yan X, Yang Y, Liu Y, Chen Y, Jia B, Xia J, Xiong Y, Zhang Z, Ding W, Huang R, Wu C. The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B. Discovery Medicine. 28: 149-158. PMID 31926586 |
0.424 |
|
| 2019 |
Huang R, Wang J, Wu W, Yan X, Wu C. Letter to the Editor: Statins and reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B. Hepatology (Baltimore, Md.). PMID 31858599 DOI: 10.1002/hep.31080 |
0.353 |
|
| 2019 |
Wang J, Wu W, Yan X, Wei J, Yao K, Yang Y, Xiong Y, Xia J, Liu Y, Chen Y, Jia B, Zhang Z, Ding W, Huang R, Wu C. HBeAg Negativity Is Associated With More Advanced Liver Fibrosis in Patients With Chronic Hepatitis B: A Propensity Score-Matching Analysis. Journal of Clinical Gastroenterology. PMID 31789771 DOI: 10.1097/MCG.0000000000001291 |
0.437 |
|
| 2019 |
Yuan L, Zou C, Ge W, Liu Y, Hu B, Wang J, Lin B, Li Y, Ma E. A novel cathepsin L inhibitor prevents the progression of idiopathic pulmonary fibrosis. Bioorganic Chemistry. 103417. PMID 31744600 DOI: 10.1016/j.bioorg.2019.103417 |
0.457 |
|
| 2019 |
Huang R, Rao H, Yang M, Gao Y, Wang J, Jin Q, Ma D, Wei L. Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy. Digestive Diseases and Sciences. PMID 31654313 DOI: 10.1007/s10620-019-05886-y |
0.39 |
|
| 2019 |
Huang R, Wang J, Zhang Z, Yan X, Wu C. Letter to the Editor: Impact of non-alcoholic steatohepatitis on liver-related outcomes in chronic hepatitis B. Hepatology (Baltimore, Md.). PMID 31587343 DOI: 10.1002/hep.30981 |
0.396 |
|
| 2019 |
Liu Y, Huangfu M, Wu P, Jiang M, Zhao X, Liang L, Xie L, Bai J, Wang J. Post-imparting Brønsted acidity into an amino-functionalized MOF as a bifunctional luminescent turn-ON sensor for the detection of aluminum ions and lysine. Dalton Transactions (Cambridge, England : 2003). PMID 31482925 DOI: 10.1039/c9dt02962a |
0.6 |
|
| 2019 |
Huang R, Wang J, Yan X, Zhang Z, Wu C. Letter to the Editor: Non-invasive markers of advanced liver fibrosis in HBV/HIV coinfected patients. Hepatology (Baltimore, Md.). PMID 31430388 DOI: 10.1002/hep.30903 |
0.365 |
|
| 2019 |
Huang R, Wang J, Yan X, Xia J, Wu C. Letter: risk of developing hepatocellular carcinoma in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation. Alimentary Pharmacology & Therapeutics. 50: 618-619. PMID 31414546 DOI: 10.1111/apt.15423 |
0.396 |
|
| 2019 |
Huang R, Wang J, Wu W, Yan X, Wu C. Letter: clinical outcomes after long-term entecavir or tenofovir treatment in patients with hepatitis D and advanced fibrosis. Alimentary Pharmacology & Therapeutics. 50: 471. PMID 31359471 DOI: 10.1111/apt.15367 |
0.362 |
|
| 2019 |
Huang R, Wu W, Wang J, Zhang Z, Wu C. Letter: use of collagen proportionate area to quantify liver fibrosis and predict clinical outcomes in non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 50: 338. PMID 31313357 DOI: 10.1111/apt.15362 |
0.371 |
|
| 2019 |
Wang H, Wang J, Huang R, Xia J, Zuo L, Yan X, Yang Y, Wu C. Red blood cell distribution width for predicting significant liver inflammation in patients with autoimmune hepatitis. European Journal of Gastroenterology & Hepatology. PMID 31107736 DOI: 10.1097/MEG.0000000000001447 |
0.405 |
|
| 2019 |
Huang R, Yao R, Wu W, Wang J, Wu C. Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients. Alimentary Pharmacology & Therapeutics. 49: 1105-1106. PMID 30920033 DOI: 10.1111/apt.15150 |
0.408 |
|
| 2019 |
Wang J, Zhang Z, Yan X, Li M, Xia J, Liu Y, Chen Y, Jia B, Zhu L, Zhu C, Huang R, Wu C. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 30765220 DOI: 10.1016/j.dld.2019.01.011 |
0.416 |
|
| 2018 |
Wang J, Yan X, Chen Y, Liu Y, Wang L, Jia B, Wang G, Xiong Y, Song P, Wu W, Xia J, Lu S, Zhang Z, Huang R, Wu C. Characteristics of hepatitis B core antibody level in the natural history of chronic hepatitis B. Discovery Medicine. 26: 119-125. PMID 30586535 |
0.401 |
|
| 2018 |
Yuan L, Sheng L, He W, Zou C, Hu B, Liu J, Ge W, Liu Y, Wang J, Ma E. Discovery of novel cathepsin inhibitors with potent anti-metastatic effects in breast cancer cells. Bioorganic Chemistry. 81: 672-680. PMID 30253340 DOI: 10.1016/j.bioorg.2018.09.029 |
0.425 |
|
| 2018 |
Ge W, Zhu X, Xu Y, Hua C, Wang J. Therapeutic effects of modified Devine surgery for concealed penis in children. Asian Journal of Surgery. PMID 30193770 DOI: 10.1016/j.asjsur.2018.06.007 |
0.399 |
|
| 2018 |
Zhao XA, Chen G, Liu Y, Chen Y, Wu H, Xiong Y, Wang G, Jia B, Li Y, Xia J, Wang J, Yan X, Zhang Z, Huang R, Wu C. Curcumin reduces Ly6C monocyte infiltration to protect against liver fibrosis by inhibiting Kupffer cells activation to reduce chemokines secretion. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 106: 868-878. PMID 30119257 DOI: 10.1016/j.biopha.2018.07.028 |
0.374 |
|
| 2018 |
Huang R, Wang J, Xia J, Zhang Z, Wu C. Platelet Count and Prediction of Bleeding in Patients With Liver Cirrhosis. The American Journal of Gastroenterology. PMID 29895981 DOI: 10.1038/s41395-018-0152-2 |
0.389 |
|
| 2018 |
Zhao XA, Chen G, Liu Y, Wu H, Chen J, Xiong Y, Tian C, Jia B, Wang G, Xia J, Chen Y, Wang J, Yan X, Zhang Z, Huang R, et al. Emodin Alleviates Liver Fibrosis of Mice by Reducing Infiltration of Gr1 Monocytes. Evidence-Based Complementary and Alternative Medicine : Ecam. 2018: 5738101. PMID 29743924 DOI: 10.1155/2018/5738101 |
0.382 |
|
| 2018 |
Huang R, Wang J, Xia J, Hao Y, Wu C. Potential clinical application of strain elastography in chronic liver diseases. Journal of Gastroenterology. PMID 29623439 DOI: 10.1007/s00535-018-1457-z |
0.359 |
|
| 2018 |
Huang R, Wang J, Xia J, Hao Y, Wu C. Platelets-to-lymphocyte ratio as a predictor of liver fibrosis and insulin resistance in hepatitis C virus infection: more evidence is needed. European Journal of Gastroenterology & Hepatology. 30: 583. PMID 29579016 DOI: 10.1097/MEG.0000000000001092 |
0.376 |
|
| 2018 |
Wang J, Yamamoto T, Bai J, Cox SJ, Korshavn KJ, Monette M, Ramamoorthy A. Real-time monitoring of the aggregation of Alzheimer's amyloid-β viaH magic angle spinning NMR spectroscopy. Chemical Communications (Cambridge, England). 54: 2000-2003. PMID 29411841 DOI: 10.1039/C8Cc00167G |
0.694 |
|
| 2018 |
Huang R, Xia J, Wang J, Zhang Z, Wu C. Red blood cell distribution width: a potential prognostic index for short-term mortality of patients admitted to emergency department for acute decompensation of liver cirrhosis? European Journal of Gastroenterology & Hepatology. 30: 328. PMID 29384764 DOI: 10.1097/MEG.0000000000001042 |
0.367 |
|
| 2018 |
Huang R, Zhao XA, Wang J, Hao Y, Wu C. Simple noninvasive tests for the detection of advanced liver fibrosis in patients with chronic hepatitis B. European Journal of Gastroenterology & Hepatology. 30: 241. PMID 29261557 DOI: 10.1097/MEG.0000000000001020 |
0.428 |
|
| 2017 |
Zhao XA, Chen GM, Liu Y, Chen YX, Wu HY, Chen J, Xiong YL, Tian C, Wang GY, Jia B, Xia J, Wang J, Yan XM, Zhang ZP, Huang R, et al. Inhibitory effect of silymarin on CCl-induced liver fibrosis by reducing Ly6C monocytes infiltration. International Journal of Clinical and Experimental Pathology. 10: 11941-11951. PMID 31966559 |
0.377 |
|
| 2017 |
Wang J, Wang N, Liu B, Bai J, Gong P, Ru G, Feng J. Preferential adsorption of the additive is not a prerequisite for cononsolvency in water-rich mixtures. Physical Chemistry Chemical Physics : Pccp. PMID 29099128 DOI: 10.1039/C7Cp04384H |
0.601 |
|
| 2017 |
Huang R, Wang J, Zhao XA, Xia J, Wu C. The impact of cirrhosis on the efficacy and safety of entecavir for patients with chronic hepatitis B. European Journal of Gastroenterology & Hepatology. 29: 1314. PMID 28953581 DOI: 10.1097/MEG.0000000000000948 |
0.403 |
|
| 2017 |
Wang J, Yan X, Yang Y, Chang H, Jia B, Zhao XA, Chen G, Xia J, Liu Y, Chen Y, Wang G, Wang L, Zhang Z, Ding W, Huang R, et al. A novel predictive model using routinely clinical parameters to predict liver fibrosis in patients with chronic hepatitis B. Oncotarget. 8: 59257-59267. PMID 28938634 DOI: 10.18632/oncotarget.19501 |
0.417 |
|
| 2017 |
Huang R, Liu Y, Wang J, Xia J, Yan X, Wu C. Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance. Journal of Hepatology. PMID 28870672 DOI: 10.1016/j.jhep.2017.07.036 |
0.359 |
|
| 2017 |
Huang R, Wang G, Tian C, Liu Y, Jia B, Wang J, Yang Y, Li Y, Sun Z, Yan X, Xia J, Xiong Y, Song P, Zhang Z, Ding W, et al. Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China. Scientific Reports. 7: 8543. PMID 28819319 DOI: 10.1038/s41598-017-09234-w |
0.408 |
|
| Show low-probability matches. |